Chalice AI’s COO and co-founder, Ali Manning, explains how the AI startup – don’t call it a custom algorithm company – is helping brands like Bayer use advertiser-specific bidding models to drive real outcomes as opposed to poor proxies.
Innovid’s new open orchestration layer aims to connect data and tech throughout the advertising process, breaking down fragmentation and silos.
Bringing media buying in-house is “chaotic and disruptive” – but totally worth it, according to Glenniss Richards, Bayer’s senior director of digital media.
Advertisers’ obsession with “following the audience” allowed low-quality sites and vanity metrics to thrive while brand integrity suffers. But a cultural shift back toward focusing on quality is underway.
Bayer partnered with its data agency, fifty-five, to develop a custom in-house creative analytics dashboard built on Google Cloud to more effectively measure and evaluate creative performance.
Martech holding company The Brandtech Group acquired Pencil, a generative AI platform for ads, on Thursday.
As COVID-19 cases spike across America, the joyous reopening is on pause. (Unless you’re Disney World, because apparently the virus has no effect on the land of enchantment and childhood dreams.) But having gone through the initial shutdown in March, brands are more prepared this time around. They’re pulling back on some of the more […]
It never ends. COVID-19 outbreaks and lockdowns of varying degrees in states such as Texas, Florida, Arizona and California mean advertisers must once again adapt their strategies. After pausing media spend in March and April, advertisers tentatively returned in late May. But the rise of coronavirus cases in more than 30 states means they’re accelerating […]
Add Bayer to the list of brands pausing paid media on Facebook for the month of July. The consumer health and pharma giant confirmed the pause with AdExchanger, but declined to share details on whether the move is directly connected to the broader Facebook boycott spearheaded by civil rights groups such as Color of Change, […]
Really though, does a pharma company like Bayer even need to advertise during a global pandemic? Actually, yes, says Bayer’s head of media in North America Josh Palau. “Right now, consumers are so in need of the products we make that anything we can do to make sure we’re front and center to get what […]
Throw a brick and you’ll hit a 2020 marketing prognosticator, but in a way there’s only one cohort whose predictions matter in this industry: the marketer, who sets strategy and writes all the checks. So we asked six leading brand marketers the following question: “What will be the biggest challenge and opportunity for marketers in […]
Data management platforms (DMPs) were once painted as a panacea for all of a marketer’s data needs – from collection, to harmonization to segmentation and syndication. But marketers have since cooled on the technology, concluding that it‘s too disjointed to perform many of the functions promised. Marketers tell AdExchanger they have struggled to achieve ROI, […]
Here’s today’s AdExchanger.com news round-up… Want it by email? Sign up here. Spoiled For Choice Vestager strikes again. Starting next year, Google will show a new “choice screen” to Android smartphone owners in Europe that prompts them to choose a default search service from a set of four companies – initially Google, Yahoo, Qwant, a French […]
Big agencies’ inability to quickly change their legacy structures has eroded their value to clients. “We are too passive,” said Nick Brien, CEO of Dentsu Aegis Network in North America, on stage at the 4A’s Decisions 2020 conference in Washington, DC on Monday. “We are slow to change. We’re too incremental. We have legacy structures […]
Consumer health and pharmaceutical giant Bayer is taking programmatic in-house. Bayer will partner with MightyHive to in-source its digital and programmatic media planning, buying, execution, strategy and analytics as well as search over the next two years. MightyHive will handle execution for the first year and phase out during 2020, Josh Palau, VP of digital […]
Now Hiring The overarching trend of brands in-housing marketing technology operations isn’t great for agencies and tech vendors. But one thing working in their favor is the challenge many brands now face securing top programmatic and data-driven talent. The pharmaceutical giant Bayer would like to more than double its 10-person programmatic and analytics team, but […]
by Allison Schiff, Alison Weissbrot, Sarah Sluis, James Hercher and Ryan Joe Getting a big brand to shift its marketing approach is about as easy as moving a planet out of orbit. Yet, many see the writing on the wall: If they don’t change, consumers will leave them behind. As such, big marketers have to […]
AdExchanger Talks is a podcast focused on data-driven marketing. Subscribe here. This episode of AdExchanger Talks is supported by Exponential. Josh Palau, VP for digital strategy at Bayer Consumer Health, spent years in agency land before going over to “the client.” In this week’s podcast, he describes how moving in-house (he has worked at brands like Comcast and […]
Brands like Uber, Ubisoft and Bayer have evolved their programmatic in-housing tactics in recent years – and all three outlined those changes at AdExchanger’s Programmatic I/O conference in San Francisco Wednesday. In the early days of in-housing, brands often bit off more than they could chew – or lacked the proper resources to implement and maintain […]
Major brands like AT&T and Bayer are on a crusade to bring transparency back to the digital media supply chain – and are hoping the blockchain-based solutions they’re testing can be an answer. “Who specifically are those tech providers [in the supply chain] and how much of a fee are they assessing to my working […]
The complexity of programmatic and the media supply chain can stump even the most sophisticated marketer. So, in September, Bayer hired Josh Palau to the new role of VP of digital and omnichannel marketing to figure out how to connect consumer touchpoints in a fragmented world. His remit is to figure out how Bayer can […]
